176 related articles for article (PubMed ID: 16324756)
1. Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats.
Soga M; Kamal FA; Watanabe K; Ma M; Palaniyandi S; Prakash P; Veeraveedu P; Mito S; Kunisaki M; Tachikawa H; Kodama M; Aizawa Y
Int J Cardiol; 2006 Jun; 110(3):378-85. PubMed ID: 16324756
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
Hanatani A; Yoshiyama M; Takeuchi K; Kim S; Nakayama K; Omura T; Iwao H; Yoshikawa J
Jpn J Pharmacol; 1998 Sep; 78(1):45-54. PubMed ID: 9804061
[TBL] [Abstract][Full Text] [Related]
3. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Arumugam S; Thandavarayan RA; Palaniyandi SS; Giridharan VV; Arozal W; Sari FR; Soetikno V; Harima M; Suzuki K; Kodama M; Watanabe K
Toxicology; 2012 Jan; 291(1-3):139-45. PubMed ID: 22120037
[TBL] [Abstract][Full Text] [Related]
4. Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Taniguchi Y; Takahashi N; Fukui A; Nagano-Torigoe Y; Thuc LC; Teshima Y; Shinohara T; Wakisaka O; Ooie T; Murozono Y; Yufu K; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
Cardiovasc Res; 2011 Dec; 92(3):439-48. PubMed ID: 21952935
[TBL] [Abstract][Full Text] [Related]
5. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
Watanabe K; Juan W; Narasimman G; Ma M; Inoue M; Saito Y; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamamoto T; Yamaguchi K; Takahashi T
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S93-7. PubMed ID: 12693379
[TBL] [Abstract][Full Text] [Related]
7. An angiotensin II type 1 receptor blocker, candesartan, increases myocardial apoptosis in rats with acute ischemia-reperfusion.
Chen M; Hamada M; Hiasa G; Suzuki M; Ikeda S; Hiwada K
Hypertens Res; 2001 May; 24(3):323-9. PubMed ID: 11409658
[TBL] [Abstract][Full Text] [Related]
8. Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
Murad HA; Gazzaz ZJ; Ali SS; Ibraheem MS
Braz J Med Biol Res; 2017 Sep; 50(11):e6665. PubMed ID: 28953991
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression.
Saegusa S; Fei Y; Takahashi T; Sumino H; Moriya J; Kawaura K; Yamakawa J; Itoh T; Morimoto S; Nakahashi T; Iwai K; Matsumoto M; Kanda T
Cardiovasc Drugs Ther; 2007 Jun; 21(3):155-60. PubMed ID: 17484035
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
Shirai K; Watanabe K; Ma M; Wahed MI; Inoue M; Saito Y; Suresh PS; Kashimura T; Tachikawa H; Kodama M; Aizawa Y
Mol Cell Biochem; 2005 Jan; 269(1-2):137-42. PubMed ID: 15786726
[TBL] [Abstract][Full Text] [Related]
11. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Sebeková K; Lill M; Boor P; Heidland A; Amann K
Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
[TBL] [Abstract][Full Text] [Related]
12. Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
Aikawa K; Sakai T; Ishibashi K; Shiomi H; Sagawa K; Kumagai S; Kataoka M; Akaihata H; Yamaguchi O
Int J Urol; 2012 May; 19(5):457-64. PubMed ID: 22320898
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
Tsutsui H; Matsushima S; Kinugawa S; Ide T; Inoue N; Ohta Y; Yokota T; Hamaguchi S; Sunagawa K
Hypertens Res; 2007 May; 30(5):439-49. PubMed ID: 17587756
[TBL] [Abstract][Full Text] [Related]
14. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Wang QD; Sjöquist PO
Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
[TBL] [Abstract][Full Text] [Related]
15. Candesartan improves survival following severe hypovolemia in pigs; a role for the angiotensin II type 2 receptor?
Laesser M; Spak E; Ewert S; Aneman A; Fandriks L
Intensive Care Med; 2005 Aug; 31(8):1109-15. PubMed ID: 15983760
[TBL] [Abstract][Full Text] [Related]
16. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of candesartan on rat diastolic heart failure.
Wake R; Kim-Mitsuyama S; Izumi Y; Yoshida K; Izumiya Y; Yukimura T; Shiota M; Yoshiyama M; Yoshikawa J; Iwao H
J Pharmacol Sci; 2005 Aug; 98(4):372-9. PubMed ID: 16079469
[TBL] [Abstract][Full Text] [Related]
18. Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system.
Pelisch N; Hosomi N; Ueno M; Masugata H; Murao K; Hitomi H; Nakano D; Kobori H; Nishiyama A; Kohno M
Hypertens Res; 2010 Feb; 33(2):161-4. PubMed ID: 19942928
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
